Literature DB >> 19812385

Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Junmei Chen1, Xiaoyun Fu, Yi Wang, Minhua Ling, Brad McMullen, John Kulman, Dominic W Chung, José A López.   

Abstract

Elevated plasma von Willebrand factor (VWF) and low ADAMTS13 activity have been reported in several inflammatory states, including sepsis and acute respiratory distress syndrome. One hallmark of inflammation is neutrophil activation and production of reactive oxygen species, including superoxide radical, hydrogen peroxide, and hypochlorous acid (HOCl). HOCl is produced from hydrogen peroxide and chloride ions through the action of myeloperoxidase. HOCl can oxidize methionine to methionine sulfoxide and tyrosine to chlorotyrosine. This is of interest because the ADAMTS13 cleavage site in VWF, the Tyr(1605)-Met(1606) peptide bond, contains both oxidation-prone residues. We hypothesized that HOCl would oxidize either or both of these residues and possibly inhibit ADAMTS13-mediated cleavage. We therefore treated ADAMTS13 substrates with HOCl and examined their oxidative modification by mass spectrometry. Met(1606) was oxidized to the sulfoxide in a concentration-dependent manner, with complete oxidation at 75muM HOCl, whereas only a miniscule percentage of Tyr(1605) was converted to chlorotyrosine. The oxidized substrates were cleaved much more slowly by ADAMTS13 than the nonoxidized substrates. A similar result was obtained with multimeric VWF. Taken together, these findings indicate that reactive oxygen species released by activated neutrophils have a prothrombotic effect, mediated in part by inhibition of VWF cleavage by ADAMTS13.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812385      PMCID: PMC2810979          DOI: 10.1182/blood-2009-03-213967

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

Review 1.  Mechanisms and consequences of neutrophil interaction with the endothelium.

Authors:  Alexander Zarbock; Klaus Ley
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

2.  A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature.

Authors:  J Carvalho-Tavares; M J Hickey; J Hutchison; J Michaud; I T Sutcliffe; P Kubes
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

3.  Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.

Authors:  P André; C V Denis; J Ware; S Saffaripour; R O Hynes; Z M Ruggeri; D D Wagner
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

4.  Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity.

Authors:  C Taggart; D Cervantes-Laurean; G Kim; N G McElvaney; N Wehr; J Moss; R L Levine
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

Review 5.  The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007).

Authors:  James N George
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

6.  Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor.

Authors:  Clemens L Bockmeyer; Ralf A Claus; Ulrich Budde; Karim Kentouche; Reinhard Schneppenheim; Wolfgang Lösche; Konrad Reinhart; Frank M Brunkhorst
Journal:  Haematologica       Date:  2008-01       Impact factor: 9.941

Review 7.  NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype.

Authors:  Rafał Dworakowski; Sara P Alom-Ruiz; Ajay M Shah
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

8.  Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.

Authors:  M P Bevilacqua; J S Pober; M E Wheeler; R S Cotran; M A Gimbrone
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

9.  Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells.

Authors:  W J Cao; M Niiya; X W Zheng; D Z Shang; X L Zheng
Journal:  J Thromb Haemost       Date:  2008-07-01       Impact factor: 5.824

10.  Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.

Authors:  Chie Morioka; Masahito Uemura; Tomomi Matsuyama; Masanori Matsumoto; Seiji Kato; Masatoshi Ishikawa; Hiromichi Ishizashi; Masao Fujimoto; Masayoshi Sawai; Motoyuki Yoshida; Akira Mitoro; Junichi Yamao; Tatsuhiro Tsujimoto; Hitoshi Yoshiji; Yasuyuki Urizono; Michiaki Hata; Kenji Nishino; Kazuo Okuchi; Yoshihiro Fujimura; Hiroshi Fukui
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

View more
  51 in total

1.  The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

Review 2.  Regulation of thrombosis and vascular function by protein methionine oxidation.

Authors:  Sean X Gu; Jeff W Stevens; Steven R Lentz
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

3.  Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging.

Authors:  Tamara Atkinson; William Packwood; Aris Xie; Sherry Liang; Yue Qi; Zaverio Ruggeri; Jose Lopez; Brian P Davidson; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2018-09-11       Impact factor: 5.251

4.  Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.

Authors:  Koya Ozawa; William Packwood; Oleg Varlamov; Yue Qi; Aris Xie; Melinda D Wu; Zaverio Ruggeri; Jose A López; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

5.  Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.

Authors:  Chi Young Shim; Ya Ni Liu; Tamara Atkinson; Aris Xie; Ted Foster; Brian P Davidson; Mackenzie Treible; Yue Qi; José A López; Adam Munday; Zaverio Ruggeri; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2015-07       Impact factor: 7.792

Review 6.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

Review 7.  von Willebrand factor: at the crossroads of bleeding and thrombosis.

Authors:  Cécile V Denis; Peter J Lenting
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

8.  Myocardial Infarction Produces Sustained Proinflammatory Endothelial Activation in Remote Arteries.

Authors:  Federico Moccetti; Eran Brown; Aris Xie; William Packwood; Yue Qi; Zaverio Ruggeri; Weihui Shentu; Junmei Chen; Jose A López; Jonathan R Lindner
Journal:  J Am Coll Cardiol       Date:  2018-08-28       Impact factor: 24.094

Review 9.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

10.  Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner.

Authors:  William E Hobbs; Emily E Moore; Rebecca A Penkala; Douglas D Bolgiano; José A López
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.